369 related articles for article (PubMed ID: 23399889)
1. Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence.
Kuzdas D; Stemberger S; Gaburro S; Stefanova N; Singewald N; Wenning GK
Exp Neurol; 2013 Sep; 247():531-6. PubMed ID: 23399889
[TBL] [Abstract][Full Text] [Related]
2. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
[TBL] [Abstract][Full Text] [Related]
3. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
Stemberger S; Poewe W; Wenning GK; Stefanova N
Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype.
Kuzdas-Wood D; Irschick R; Theurl M; Malsch P; Mair N; Mantinger C; Wanschitz J; Klimaschewski L; Poewe W; Stefanova N; Wenning GK
PLoS One; 2015; 10(10):e0136575. PubMed ID: 26496712
[TBL] [Abstract][Full Text] [Related]
5. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
Stefanova N; Kaufmann WA; Humpel C; Poewe W; Wenning GK
Acta Neuropathol; 2012 Jul; 124(1):51-65. PubMed ID: 22491959
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.
Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F
Cells; 2020 Oct; 9(11):. PubMed ID: 33138150
[TBL] [Abstract][Full Text] [Related]
7. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
[TBL] [Abstract][Full Text] [Related]
8. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.
Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F
Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499
[TBL] [Abstract][Full Text] [Related]
9. Bladder dysfunction in a transgenic mouse model of multiple system atrophy.
Boudes M; Uvin P; Pinto S; Voets T; Fowler CJ; Wenning GK; De Ridder D; Stefanova N
Mov Disord; 2013 Mar; 28(3):347-55. PubMed ID: 23426727
[TBL] [Abstract][Full Text] [Related]
10. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy.
Mészáros L; Riemenschneider MJ; Gassner H; Marxreiter F; von Hörsten S; Hoffmann A; Winkler J
Acta Neuropathol Commun; 2021 Apr; 9(1):68. PubMed ID: 33853667
[TBL] [Abstract][Full Text] [Related]
11. ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy.
Heras-Garvin A; Refolo V; Schmidt C; Malfertheiner K; Wenning GK; Bradbury M; Stamler D; Stefanova N
Mov Disord; 2021 Nov; 36(11):2605-2614. PubMed ID: 34236731
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein transgenic mice: relevance to multiple system atrophy.
Fillon G; Kahle PJ
Mov Disord; 2005 Aug; 20 Suppl 12():S64-6. PubMed ID: 16092093
[TBL] [Abstract][Full Text] [Related]
13. Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy.
Rockenstein E; Ubhi K; Inglis C; Mante M; Patrick C; Adame A; Masliah E
Neuroreport; 2012 Mar; 23(4):259-64. PubMed ID: 22314685
[TBL] [Abstract][Full Text] [Related]
14. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
[TBL] [Abstract][Full Text] [Related]
15. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
[TBL] [Abstract][Full Text] [Related]
16. Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.
Kaindlstorfer C; Sommer P; Georgievska B; Mather RJ; Kugler AR; Poewe W; Wenning GK; Stefanova N
Neurotox Res; 2015 Oct; 28(3):185-94. PubMed ID: 26194617
[TBL] [Abstract][Full Text] [Related]
17. Multiple system atrophy: alpha-synuclein and neuronal degeneration.
Yoshida M
Neuropathology; 2007 Oct; 27(5):484-93. PubMed ID: 18018485
[TBL] [Abstract][Full Text] [Related]
18. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
Jellinger KA; Seppi K; Wenning GK
Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.
Stefanova N; Georgievska B; Eriksson H; Poewe W; Wenning GK
Neurotox Res; 2012 May; 21(4):393-404. PubMed ID: 22161470
[TBL] [Abstract][Full Text] [Related]
20. Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.
Jellinger KA
J Alzheimers Dis; 2018; 62(3):1141-1179. PubMed ID: 28984582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
